Wells Fargo
WINT

Wells Fargo’s Windtree Therapeutics Inc WINT Stock Holding History

Wells Fargo’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4
Closed – – 6695
2017
Q1 		$0 Sell
4
-64
-94% -$83 ﹤0.01% 6697
2016
Q4 		$0 Hold
68
– – ﹤0.01% 6628
2016
Q3 		$0 Sell
68
-634
-90% -$1.38K ﹤0.01% 6510
2016
Q2 		$1K Sell
702
-173
-20% -$418 ﹤0.01% 6053
2016
Q1 		$1K Sell
875
-15
-2% -$32 ﹤0.01% 6146
2015
Q4 		$3K Sell
890
-5
-0.6% -$21 ﹤0.01% 5993
2015
Q3 		$4K Hold
895
– – ﹤0.01% 5917
2015
Q2 		$9K Buy
895
+165
+23% +$2.32K ﹤0.01% 5859
2015
Q1 		$12K Buy
730
+29
+4% +$571 ﹤0.01% 5585
2014
Q4 		$11K Sell
701
-179
-20% -$3.94K ﹤0.01% 5603
2014
Q3 		$23K Buy
880
+176
+25% +$4.25K ﹤0.01% 5242
2014
Q2 		$18K Sell
704
-82,928
-99% -$2.12M ﹤0.01% 5424
2014
Q1 		$2.52M Sell
83,632
-96,864
-54% -$3.26M ﹤0.01% 2835
2013
Q4 		$5.68M Sell
180,496
-25,490
-12% -$797K ﹤0.01% 2171
2013
Q3 		$5.65M Sell
205,986
-27,996
-12% -$679K ﹤0.01% 2104
2013
Q2 		$4.98M Buy
+233,982
New +$5.76M ﹤0.01% 2125

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wells Fargo's WINT Position: Q2 2017 in Review

Wells Fargo sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 4 shares.

Wells Fargo first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $5.68M in Q4 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Wells Fargo reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Wells Fargo sold 4 Windtree Therapeutics Inc shares in Q2 2017.
  • Wells Fargo first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Wells Fargo's Windtree Therapeutics Inc position peaked at $5.68M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Wells Fargo's 13F filing for Q2 2017, filed 10 Aug 2017.